Plan comparison of prostate stereotactic radiotherapy in spacer implant patients-Reference-Cited by-同舟云学术

Plan comparison of prostate stereotactic radiotherapy in spacer implant patients

Published:2021-08-06 Issue:9 Volume:22 Page:280-288
ISSN:1526-9914
Container-title:Journal of Applied Clinical Medical Physics
language:en
Short-container-title:J Appl Clin Med Phys

Author:

Oki Yuya¹^ORCID,Uehara Kazuyuki¹,Mizonobe Kazufusa¹,Akasaka Hiroaki¹²^ORCID,Shiota Yuichirou³,Sakamoto Risako³,Harada Aya¹,Kitatani Keiji¹,Yabuuchi Tomonori¹,Miyazaki Shuichirou¹,Hattori Takayuki¹,Mayahara Hiroshi¹

Affiliation:

1. Division of Radiation Oncology Kobe Minimally Invasive Cancer Center Kobe Hyogo Japan

2. Division of Radiation Oncology Kobe University Graduate School of Medicine Kobe Hyogo Japan

3. Division of Radiological Technology Kobe Minimally Invasive Cancer Center Kobe Hyogo Japan

Publisher

Wiley

Subject

Radiology Nuclear Medicine and imaging,Instrumentation,Radiation

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/acm2.13387

Reference35 articles.

1. Cancer statistics, 2019

2. Randomized Trial of a Hypofractionated Radiation Regimen for the Treatment of Localized Prostate Cancer

3. Hyprofractionated Versus Conventionally Fractionated Radiation Therapy for Patients with Intermediate- or High-Risk, Localized, Prostate Cancer: 7-Year Outcomes From the Randomized, Multicenter, Open-Label, Phase 3 HYPRO Trial

4. Real-world dosimetric comparison between CyberKnife SBRT and HDR brachytherapy for the treatment of prostate cancer

5. Intensity-modulated fractionated radiotherapy versus stereotactic body radiotherapy for prostate cancer (PACE-B): acute toxicity findings from an international, randomised, open-label, phase 3, non-inferiority trial